查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1820167

免疫组织化学市场报告（按产品（抗体、设备、试剂、试剂盒）、应用（诊断、药物检测）、最终用途（医院和诊断实验室、研究机构等）和地区划分，2025 年至 2033 年）

Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End Use (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球免疫组织化学市场规模达28亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到50亿美元，2025-2033年期间的复合年增长率（CAGR）为6.5%。慢性病盛行率的上升、个人化医疗需求的不断增长、诊断技术的显着进步、医疗基础设施投资的不断增加以及人口老化加剧是推动市场成长的主要因素。

免疫组织化学市场分析：

  • 主要市场驱动因素：传染病和慢性病发病率的不断上升，对先进诊断解决方案的需求日益增长，这是市场的主要驱动因素。个人化医疗的广泛应用，在很大程度上依赖生物标记识别，进一步刺激了对免疫组织化学的需求。诊断技术的重大进步提高了免疫组织化学检测的准确性和效率。
  • 主要市场趋势：先进成像技术的日益整合和自动化，提升了诊断通量和准确性，这是市场的主要趋势之一。伴随诊断和精准医疗的兴起，强调了个人化治疗策略。多重检测技术的不断发展，使得同时检测多个生物标记成为可能，从而提高了效率。
  • 地理趋势：北美是免疫组织化学市场最大的地区。加拿大和美国高度重视癌症研究和诊断技术的进步，推动了市场的成长。这主要得益于其雄厚的医疗保健支出和完善的医疗基础设施。个人化医疗和基于生物标记的检测（尤其是在肿瘤学领域）的广泛应用，正在推动整个地区的市场成长。
  • 竞争格局：免疫组织化学行业的一些主要市场参与者包括 Abcam plc、Agilent Technologies Inc.、Beckman Coulter Inc.（Danaher Corporation）、Becton Dickinson and Company、Bio SB Inc.、Bio-Rad Laboratories Inc.、Bio-Techne Corporation、Cell Signaling Technology Inc.、F. Hoff Hr.A. Fisher、Mr. Fisher Inc.）、Mr. Hr. Fisher.
  • 挑战与机会：市场面临各种挑战，包括先进成像系统和试剂的高成本、缺乏能够解读复杂免疫组化资料的熟练专业人员，以及严格的产品审批监管要求。然而，市场也面临着许多机会，例如对个人化医疗和标靶治疗的需求日益增长，这些治疗方案高度依赖免疫组化标记物来制定有效的治疗方案。

免疫组织化学市场趋势：

慢性病盛行率不断上升

包括癌症在内的慢性疾病发生率不断上升，推动了对精准诊断和预后工具的需求。免疫组织化学技术对于检测癌症和其他疾病的生物标记至关重要，有助于精准诊断和製定治疗方案。根据世界卫生组织 (WHO) 发布的资料显示，2022 年全球新增癌症病例约 2,000 万例，死亡人数约 970 万人。癌症确诊后 5 年内存活的人数估计为 5,350 万人。大约五分之一的人一生中会罹患癌症，大约九分之一的男性和十二分之一的女性死于癌症。各大主要参与者透过推出更有效的产品和服务，恰如其分地应对了这项激增的需求。例如，2024 年 4 月，生命科学研究和临床诊断产品的全球领导者伯乐生命医学有限公司 (Bio-Rad Laboratories, Inc.) 宣布推出首款超灵敏多重数位 PCR 检测试剂盒 ddPLEX ESR1 突变检测试剂盒。此检测方法扩展了该公司针对肿瘤学市场的微滴式数位PCR (ddPCR) 产品线。该技术高度灵敏且多重突变检测方法有助于转化研究、疗法选择和疾病监测。预计这将进一步提升未来几年免疫组织化学市场的预测。

重大技术进步

显微镜、染色技术和数位成像领域的技术创新日益增强，提高了免疫组织化学检测程序的有效性和效率，使其成为详细组织分析的首选方法。例如，2023年5月，全球领先的医疗技术公司BD（碧迪公司）宣布在全球推出一款新型细胞分选仪，该仪器提供两项突破性技术，使研究人员能够发现传统流式细胞术实验中无法获取的更详细的细胞分选资讯。借助BD CellView影像技术，研究人员可以查看单一细胞的详细显微影像，并根据视觉特征进行高速分选，从而即时确认结果。透过BD SpectalFX技术，研究人员可以实现全光谱细胞分选，并结合全新模组化光学架构和系统感知演算法带来的扩展性能，在简化的工作流程中执行高参数实验。

个人化医疗日益受到关注

个人化医疗的日益普及，尤其是在肿瘤学领域，推动了对免疫组织化学的需求，以识别特定的分子标靶并根据患者的个别情况制定治疗方案，从而改善治疗效果。例如，2023 年 6 月，全球服务科学领导者赛默飞世尔科技宣布推出 Gibco OncoPro 肿瘤类细胞培养基试剂盒，这是第一种专门为扩增来自多种癌症适应症的患者来源的肿瘤类细胞或癌症类器官而开发的商用培养基。同样，2023 年 1 月，班加罗尔阿波罗癌症中心推出了印度首个 AI 精准肿瘤中心 (POC)，这项重大倡议将大幅提高肿瘤治疗的品质。该中心将帮助肿瘤学家、患者和照护者在规定时间内获得最佳结果，并利用 AI 提供的巨大可能性。这正在影响全球免疫组织化学市场的收入。

免疫组织化学市场细分：

按产品分类：

  • 抗体
    • 一抗
    • 二抗
  • 装置
    • 玻片染色系统
    • 组织微阵列
    • 组织处理系统
    • 幻灯片扫描仪
    • 其他的
  • 试剂
    • 组织学染色
    • 封闭血清和试剂
    • 显色底物
    • 固定试剂
    • 稳定剂
    • 有机溶剂
    • 蛋白水解酶
    • 稀释剂
  • 套件

抗体占大部分市场份额

疾病诊断和研究需求日益增长，尤其是癌症和传染病，提升了对特异性抗体的需求。抗体工程领域的不断创新提高了特异性和灵敏度，提高了诊断的准确性。不断扩展的生物医学研究需要多样化的抗体来进行详细的细胞和分子研究。个人化治疗方法需要精确的生物标记识别，这促进了标靶抗体的使用。例如，2023年8月，再生元製药公司宣布，美国生物医学高级研究与开发管理局（BARDA）已与再生元达成协议，支持其用于预防SARS-CoV-2感染的下一代COVID-19单株抗体疗法的临床开发、临床生产和监管许可流程。

按应用分类：

  • 诊断
    • 癌症
    • 传染病
    • 心血管疾病
    • 自体免疫疾病
    • 糖尿病
    • 肾臟疾病
  • 药物检测

诊断占产业最大份额

心血管疾病、传染病、癌症、自体免疫疾病、肾臟病和糖尿病病例的不断增加，对先进的诊断方法提出了更高的要求。同时，基于免疫组织化学检测的特定生物标记的个人化治疗方案也日益受到重视。染色技术的显着改进和新兴技术的出现提高了疾病诊断的准确性和效率。日益增长的研究活动需要详细的细胞分析，这促进了免疫组织化学在疾病机制和病理学理解中的应用。这进一步推动了免疫组织化学市场对诊断产品的需求成长。

依最终用途分类：

  • 医院和诊断实验室
  • 研究机构
  • 其他的

医院和诊断实验室是领先的细分市场

慢性病（尤其是癌症）发生率的上升，推动了对免疫组织化学等精准诊断工具的需求，这些工具旨在准确识别和分类疾病状态。数位成像系统和染色技术的重大创新提升了免疫组织化学的诊断能力和通量，使其在临床应用中更具吸引力。诊断流程中对高品质和监管标准的日益重视，使得像免疫组织化学这样可靠的技术成为必要。医疗基础设施和诊断服务投资的不断增加，推动了已开发市场和新兴市场对免疫组织化学等先进诊断方法的采用。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大的免疫组织化学市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是免疫组织化学最大的区域市场。

癌症和其他慢性病病例的增加推动了对免疫组织化学等精确诊断方法的需求，以识别有效治疗的生物标记物，这正在影响整个地区的市场成长。完善的医疗设施和雄厚的研发资金正在促进先进诊断技术的采用。根据美国国家医学图书馆的资料，预计到 2024 年，美国将新增 2,001,140 例癌症病例，并有 611,720 例癌症死亡病例。到 2021 年，癌症死亡率持续下降，自 1991 年以来避免了 400 多万人死亡，这得益于吸烟率的下降、某些癌症的早期发现以及辅助和转移性治疗方案的改进。

（请注意，这只是关键参与者的部分名单，完整名单将在报告中提供。）

  • 市场竞争激烈，安捷伦科技、赛默飞世尔科技和罗氏诊断等主要参与者占据主导地位。这些公司专注于创新和策略合作，以增强其产品组合。其他重要公司，例如默克集团、Bio-Rad Laboratories 和丹纳赫集团，则强调透过合作和收购扩大其全球影响力。 2023 年 2 月，安捷伦科技公司推出了一款整合解决方案，将其 xCELLigence RTCA HT 平台与 Bio Tek BioSpa 8 自动培养箱结合。这项新开发成果提供了更高水准的工作流程自动化，从而可以进一步创建用于免疫肿瘤学的无标记高通量效力检测，以及用于疫苗市场的高通量病毒细胞病变效应 (CPE) 检测。

本报告回答的关键问题：

  • 全球免疫组织化学市场迄今表现如何，未来几年将如何表现？
  • 全球免疫组织化学市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球免疫组织化学市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表了最具吸引力的免疫组织化学市场？
  • 根据产品，市场是如何分類的？
  • 免疫组织化学市场上最有吸引力的产品是什么？
  • 根据应用，市场是如何分類的？
  • 免疫组织化学市场中最具吸引力的应用是什么？
  • 根据最终用途，市场是如何分類的？
  • 免疫组织化学市场中最具吸引力的最终用途是什么？
  • 市场的竞争结构是怎么样的？
  • 全球免疫组织化学市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球免疫组织化学市场迄今表现如何，未来几年将如何表现？
  • 全球免疫组织化学市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球免疫组织化学市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表了最具吸引力的免疫组织化学市场？
  • 根据产品，市场是如何分類的？
  • 免疫组织化学市场上最有吸引力的产品是什么？
  • 根据应用，市场是如何分類的？
  • 免疫组织化学市场中最具吸引力的应用是什么？
  • 根据最终用途，市场是如何分類的？
  • 免疫组织化学市场中最具吸引力的最终用途是什么？
  • 市场的竞争结构是怎么样的？
  • 全球免疫组织化学市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球免疫组织化学市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 抗体
    • 关键部分
      • 一抗
      • 二抗
  • 装置
    • 关键部分
      • 玻片染色系统
      • 组织微阵列
      • 组织处理系统
      • 幻灯片扫描仪
      • 其他的
  • 试剂
    • 关键部分
      • 组织学染色
      • 封闭血清和试剂
      • 显色底物
      • 固定试剂
      • 稳定剂
      • 有机溶剂
      • 蛋白水解酶
      • 稀释剂
  • 套件

第七章：市场区隔：依应用

  • 诊断
    • 关键部分
      • 癌症
      • 传染病
      • 心血管疾病
      • 自体免疫疾病
      • 糖尿病
      • 肾臟疾病
  • 药物检测

第 8 章：市场区隔：最终用途别

  • 医院和诊断实验室
  • 研究机构
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abcam plc
    • Agilent Technologies Inc.
    • Beckman Coulter Inc. (Danaher Corporation)
    • Becton Dickinson and Company
    • Bio SB Inc.
    • Bio-Rad Laboratories Inc.
    • Bio-Techne Corporation
    • Cell Signaling Technology Inc.
    • F. Hoffmann-La Roche AG
    • Merck KGaA
    • Perkinelmer Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4404

The global immunohistochemistry market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.5% during 2025-2033. The rising prevalence of chronic diseases, the increasing demand for personalized medicines, significant advancements in diagnostic techniques, growing investments in healthcare infrastructure, and the rising aging population are some of the major factors propelling the growth of the market.

Immunohistochemistry Market Analysis:

  • Major Market Drivers: The growing incidence of infectious and chronic diseases which necessitate advanced diagnostic solutions represent the major drivers of the market. The widespread adoption of personalized medicine, which relies heavily on biomarker identification is further stimulating the demand for immunohistochemistry. Significant technological advancements in diagnostic techniques enhance the accuracy and efficiency of immunohistochemistry tests.
  • Key Market Trends: The increasing integration and automation of advanced imaging technologies to enhance diagnostic throughput and accuracy represents one of the key trends in the market. The rising shift toward companion diagnostic and precision medicine, emphasizes personalized treatment strategies. The growing development of multiplex assays allows simultaneous detection of multiple biomarkers thus increasing efficiency.
  • Geographical Trends: North America accounts for the largest region in the immunohistochemistry market. The strong emphasis on cancer research and diagnostic advancements in Canada and the US is driving the market growth. This is primarily due to the substantial healthcare spending and well-established medical infrastructure. The widespread adoption of personalized medicine and biomarker-based testing, particularly in oncology is fueling the market growth across the region.
  • Competitive Landscape: Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc., among many others.
  • Challenges and Opportunities: The market faces various challenges in the market including high costs associated with advanced imaging systems and reagents, a lack of skilled professionals capable of interpreting complex immunohistochemical data, and strict regulatory requirements for product approvals. However, the market faces several opportunities such as the rising demand for personalized medicine and targeted therapies that rely heavily on immunohistochemical markers for effective treatment planning.

Immunohistochemistry Market Trends:

Increasing Prevalence of Chronic Diseases

The rising incidence of chronic diseases including cancer is driving the demand for accurate diagnostic and prognostic tools. Immunohistochemistry is crucial for detecting biomarkers in cancer and other diseases, thus aiding in precise diagnosis and treatment planning. According to data published by the World Health Organization (WHO), in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. The estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. About 1 in 5 people develop cancer in their lifetime, and approximately 1 in 9 men and 1 in 12 women die from the disease. This surge is aptly met by the key players by introducing more effective products and services. For instance, in April 2024, Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ESR1 Mutation Detection Kit. The assay expands the company's Droplet Digital PCR (ddPCR) offering for the oncology market, where highly sensitive and multiplexed mutation detection assays aid translational research, therapy selection, and disease monitoring. This is further expected to boost the immunohistochemistry market forecast over the coming years.

Significant Technological Advancement

The growing technological innovations in microscopy, staining techniques, and digital imaging enhance the effectiveness and efficiency of immunohistochemistry procedures, thereby making it a preferred method for detailed tissue analysis. For instance, in May 2023, BD (Becton, Dickinson, and Company), a leading global medical technology company, announced the worldwide commercial launch of a new world sales sorting instrument offering two breakthrough technologies that enable researchers to uncover more detailed information about sales that were previously invisible in traditional flow cytometry experiments. With BD CellView Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time. With BD SpectalFX Technology, researchers can achieve full spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high parameter experiments within a simplified workflow.

Rising Focus on Personalized Medicine

The increasing shift toward personalized medicine, especially in oncology, is driving the need for immunohistochemistry to identify specific molecular targets and tailor treatments to individual patient profiles, thus improving therapeutic outcomes. For instance, in June 2023, Thermo Fisher Scientific, the world leader in serving science, announced the launch of Gibco OncoPro Tumor Roid Culture Medium Kit, the first commercially available culture medium specifically developed for the expansion of patient-derived tumoroids, or cancer organoids, from multiple cancer indications. Similarly, in January 2023, Apollo Cancer Center, Bengaluru, launched India's first AI Precision Oncology Center (POC) in a significant move that will substantially enhance the quality of oncology care. The Center will help the oncologists, patients, and caregivers to arrive at the best possible results in a time-bound manner the enormous possibilities offered by AI. This is influencing the immunohistochemistry market revenue across the globe.

Immunohistochemistry Market Segmentation:

Breakup by Product:

  • Antibodies
    • Primary Antibodies
    • Secondary Antibodies
  • Equipment
    • Slide Staining Systems
    • Tissue Microarrays
    • Tissue Processing Systems
    • Slide Scanners
    • Others
  • Reagents
    • Histological Stains
    • Blocking sera and Reagents
    • Chromogenic Substrates
    • Fixation Reagents
    • Stabilizers
    • Organic Solvents
    • Proteolytic Enzymes
    • Diluents
  • Kits

Antibodies accounts for the majority of the market share

The increasing need for disease diagnosis and research, especially cancers and infectious diseases is elevating the demand for specific antibodies. The rising innovations in antibody engineering improve specificity and sensitivity, enhancing diagnostic accuracy. The expanding biomedical research necessitates diverse antibodies for detailed cellular and molecular studies. Personalized treatment approaches require precise biomarker identification, boosting the use of targeted antibodies. For instance, in August 2023, Regeneron Pharmaceuticals, Inc. announced that the Biomedical Advanced Research and Development (BARDA)authority has agreed with Regeneron to support clinical development, clinical manufacturing, and the regulatory licensure process of on next-generation COVID-19 monoclonal antibody therapy for the prevention of SARS-CoV-2 infection.

Breakup by Application:

  • Diagnostics
    • Cancer
    • Infectious Diseases
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Diabetes Mellitus
    • Nephrological Diseases
  • Drug Testing

Diagnostics holds the largest share of the industry

The increasing cases of cardiovascular, infectious diseases, cancer, autoimmune, nephrological conditions, and diabetes necessitate advanced diagnostic methods. In line with this, the enhancing focus on personalized treatment plans based on specific biomarkers detected through immunohistochemistry. Significant improvements in staining techniques and emerging technologies improve the accuracy and efficiency of disease diagnosis. The growing research activities require detailed cellular analysis, promoting the use of immunohistochemistry in understanding disease mechanisms and pathology. This is further driving the demand for diagnostics in the immunohistochemistry market growth.

Breakup by End-Use:

  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Others

Hospitals and Diagnostic Laboratories represents the leading market segment

The rising rates of chronic diseases particularly cancers, are driving the demand for precise diagnostic tools such as immunohistochemistry to accurately identify and classify disease states. Significant innovations in digital imaging systems and staining techniques enhance the diagnostic capabilities and throughput of immunohistochemistry, making it more appealing for clinical settings. The rising focus on adherence to high quality and regulatory standards in diagnostic processes necessitates reliable techniques like immunohistochemistry. The increasing investments in healthcare infrastructure and diagnostic services boost the adoption of advanced diagnostic methods, such as immunohistochemistry, in both developed and emerging markets.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest immunohistochemistry market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for immunohistochemistry.

The rising cases of cancer and other chronic conditions are driving the demand for precise diagnostic methods like immunohistochemistry to identify biomarkers for effective treatment which is influencing the market growth across the region. The well-established healthcare facilities and robust funding research and development (R&D) are facilitating the adoption of advanced diagnostic technologies. According to the data from the National Library of Medicine, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the immunohistochemistry industry include Abcam plc, Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, Bio SB Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Cell Signaling Technology Inc., F. Hoffmann-La Roche AG, Merck KGaA, Perkinelmer Inc. and Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • The market is highly competitive, with key players like Agilent Technologies, Thermo Fisher Scientific, and Roche Diagnostics dominating. These players focus on innovation and strategic partnerships to enhance their product portfolios. Other significant companies such as Merk Group, Bio-Rad Laboratories, and Danaher Corporation, emphasize expanding their global footprints through collaborations and acquisitions. In February 2023, Agilent Technologies Inc. introduced an integrated solution that combines their xCELLigence RTCA HT platform with the Bio Tek BioSpa 8 Automated Incubator. This new development offers a higher level of workflow automation, allowing further creation of label-free high throughput potency assays for immune-oncology and high throughput viral cytopathic effects (CPE) assays for the vaccine market.

Key Questions Answered in This Report:

  • How has the global immunohistochemistry market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global immunohistochemistry market?
  • What is the impact of each driver, restraint, and opportunity on the global immunohistochemistry market?
  • What are the key regional markets?
  • Which countries represent the most attractive immunohistochemistry market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the immunohistochemistry market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the immunohistochemistry market?
  • What is the breakup of the market based on the end-use?
  • Which is the most attractive end-use in the immunohistochemistry market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global immunohistochemistry market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Immunohistochemistry Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Antibodies
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Primary Antibodies
      • 6.1.2.2 Secondary Antibodies
    • 6.1.3 Market Forecast
  • 6.2 Equipment
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Slide Staining Systems
      • 6.2.2.2 Tissue Microarrays
      • 6.2.2.3 Tissue Processing Systems
      • 6.2.2.4 Slide Scanners
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Reagents
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Histological Stains
      • 6.3.2.2 Blocking sera and Reagents
      • 6.3.2.3 Chromogenic Substrates
      • 6.3.2.4 Fixation Reagents
      • 6.3.2.5 Stabilizers
      • 6.3.2.6 Organic Solvents
      • 6.3.2.7 Proteolytic Enzymes
      • 6.3.2.8 Diluents
    • 6.3.3 Market Forecast
  • 6.4 Kits
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Diagnostics
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Cancer
      • 7.1.2.2 Infectious Diseases
      • 7.1.2.3 Cardiovascular Diseases
      • 7.1.2.4 Autoimmune Diseases
      • 7.1.2.5 Diabetes Mellitus
      • 7.1.2.6 Nephrological Diseases
    • 7.1.3 Market Forecast
  • 7.2 Drug Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Diagnostic Laboratories
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Research Institutes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abcam plc
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio SB Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Bio-Rad Laboratories Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Bio-Techne Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Cell Signaling Technology Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 F. Hoffmann-La Roche AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 SWOT Analysis
    • 14.3.10 Merck KGaA
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Perkinelmer Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Immunohistochemistry Market: Major Drivers and Challenges
  • Figure 2: Global: Immunohistochemistry Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Immunohistochemistry Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Immunohistochemistry Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Immunohistochemistry Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Immunohistochemistry Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Immunohistochemistry Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Immunohistochemistry (Antibodies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Immunohistochemistry (Antibodies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Immunohistochemistry (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Immunohistochemistry (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Immunohistochemistry (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Immunohistochemistry (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Immunohistochemistry (Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Immunohistochemistry (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Immunohistochemistry (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Immunohistochemistry (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Immunohistochemistry (Drug Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Immunohistochemistry (Drug Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Immunohistochemistry (Hospitals and Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Immunohistochemistry (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Immunohistochemistry (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Immunohistochemistry (Other End Uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Immunohistochemistry (Other End Uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: North America: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: North America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: United States: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Canada: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Canada: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Asia-Pacific: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Asia-Pacific: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: China: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: China: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Japan: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Japan: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: India: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: India: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: South Korea: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: South Korea: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Australia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Australia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Indonesia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Indonesia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Europe: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Europe: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Germany: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Germany: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: France: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: France: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: United Kingdom: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: United Kingdom: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Italy: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Italy: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Spain: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Spain: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Russia: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Russia: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Latin America: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Latin America: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Brazil: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Brazil: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Mexico: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Mexico: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Middle East and Africa: Immunohistochemistry Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Middle East and Africa: Immunohistochemistry Market: Breakup by Country (in %), 2024
  • Figure 74: Middle East and Africa: Immunohistochemistry Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Global: Immunohistochemistry Industry: SWOT Analysis
  • Figure 76: Global: Immunohistochemistry Industry: Value Chain Analysis
  • Figure 77: Global: Immunohistochemistry Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Immunohistochemistry Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Immunohistochemistry Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Immunohistochemistry Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Immunohistochemistry Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Immunohistochemistry Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Immunohistochemistry Market: Competitive Structure
  • Table 7: Global: Immunohistochemistry Market: Key Players